Reply to B. P. L. Wijnhoven et al and F. Nuytens et al

Affiliations

Comment

Michael O Meyers. J Clin Oncol. 2021.

. 2021 Jan 1;39(1):93-94.

doi: 10.1200/JCO.20.02390. Epub 2020 Sep 18.

¹ Michael O. Meyers, MD, Department of Surgery, University of North Carolina School of Medicine, Chapel Hill, NC.

No abstract available

Comment on

Implementation of Minimally Invasive Esophagectomy From a Randomized Controlled Trial Setting to National Practice.
Markar SR, Ni M, Gisbertz SS, van der Werf L, Straatman J, van der Peet D, Cuesta MA, Hanna GB, van Berge Henegouwen MI; Dutch Upper GI Cancer Audit and TIME Study Group. Markar SR, et al. J Clin Oncol. 2020 Jul 1;38(19):2130-2139. doi: 10.1200/JCO.19.02483. Epub 2020 May 18. J Clin Oncol. 2020. PMID: 32421440 Free PMC article. Clinical Trial.
Hybrid Minimally Invasive Esophagectomy to the Rescue: A Valid Alternative for Phased Dissemination of TMIE?
Nuytens F, Voron T, Piessen G. Nuytens F, et al. J Clin Oncol. 2021 Jan 1;39(1):91-92. doi: 10.1200/JCO.20.01964. Epub 2020 Sep 18. J Clin Oncol. 2021. PMID: 32946359 No abstract available.
Minimally Invasive Esophagectomy: Time to Reflect on Contemporary Outcomes.
Wijnhoven BPL, Lagarde SM. Wijnhoven BPL, et al. J Clin Oncol. 2021 Jan 1;39(1):90-91. doi: 10.1200/JCO.20.01620. Epub 2020 Sep 18. J Clin Oncol. 2021. PMID: 32946360 No abstract available.